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For the evaluation of stereospecificity of rat and human cytosolic carbonyl reductases and 
activity of microsomal oxidases involved in nabumetone biotransformation, a new chiral 
high-performance liquid chromatographic method was developed. The prepared  
LLE-HPLC-PDA method enabled extraction, separation and ultraviolet detection of prochiral 
nabumetone and its five phase I metabolites including enantiomers of two chiral 
biotransformation products of carbonyl reduction. Methyl ester of naproxen served  
as an internal standard. Diethyl ether was used for liquid-liquid extraction (LLE) of 
biomatrices. Chiralcel OD-R 250 mm×4.6 mm column with a mobile phase methanol–1M 
NaClO4/HClO4 aqueous solution pH=3 (75:25, v/v) were employed in isocratic sufficient 
separation of nine analytes. The whole analysis lasted 60 minutes at the flow rate  
of 0.5 ml/min. The column effluent was monitored using a photodiode-array detector (scan  
or single wavelength at λ=265 nm). The results of in vitro nabumetone biotransformation  
in cytosole and microsomal fraction of liver cells of two species (rat vs. human) were 
compared and enantiomeric excess of chiral nabumetone metabolites was evaluated. 
Stereospecificity in the rat cytosolic carbonyl reductases to nabumetone was observed: 
enantiomeric ratio of (+)-reduced nabumetone vs. (-)-reduced nabumetone was found to be 
10 % vs. 90 %). The proposed chiral HPLC-PDA method complements previous 
chromatographic methods developed for the study of nabumetone phase I and phase II 
biotransformation and was successfully employed in rug-metabolism-tracking. 
